Keloid Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030

Keloid Treatment Trends and Forecast

The future of the global keloid treatment market looks promising with opportunities in the hospitals, dermatology clinics, and ambulatory surgical centers (ASCS) markets. The global keloid treatment market is expected to reach an estimated $4.43 billion by 2030 with a CAGR of 3.0% from 2024 to 2030. The major drivers for this market are rise in burn cases and auto accidents, developments in keloid treatment methods, and growing acceptance of cosmetic surgery.

A more than 150-page report is developed to help in your business decisions.

Keloid Treatment by Segment

The study includes a forecast for the global keloid treatment by treatment, end use industry, and region.

Keloid Treatment Market by Treatment [Shipment Analysis by Value from 2018 to 2030]:

• Occlusive Dressing
• Compression Therapy
• Cryosurgery
• Excision
• Radiation Therapy
• Laser Therapy
• Interferon Therapy
• Intralesional Corticosteroid Injections
• Others

Keloid Treatment Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals
• Dermatology Clinics
• Ambulatory Surgical Centers (ASCs)
• Others

Keloid Treatment Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Keloid Treatment Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies keloid treatment companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the keloid treatment companies profiled in this report include-

• Novartis
• Sensus Healthcare
• Rxi Pharmaceuticals
• Sonoma Pharmaceuticals
• Perrigo Company
• Bristol-Myers Squibb Company
• Pacific World Corporation
• Valeant Pharmaceuticals International
• Revitol Corporation
• Avita Medical Limited

Keloid Treatment Market Insights

Lucintel forecasts that intralesional corticosteroid injections is expected to witness highest growth over the forecast period.

North America is expected to witness highest growth over the forecast period.

Features of the Global Keloid Treatment Market

Market Size Estimates: Keloid treatment market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Keloid treatment market size by treatment, end use industry, and region in terms of value ($B).

Regional Analysis: Keloid treatment market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different treatment, end use industry, and regions for the keloid treatment market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the keloid treatment market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the keloid treatment market size?

Answer: The global keloid treatment market is expected to reach an estimated $4.43 billion by 2030.

Q.2 What is the growth forecast for keloid treatment market?

Answer: The global keloid treatment market is expected to grow with a CAGR of 3.0% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the keloid treatment market?

Answer: The major drivers for this market are rise in burn cases and auto accidents, developments in keloid treatment methods, and growing acceptance of cosmetic surgery.

Q4. What are the major segments for keloid treatment market?

Answer: The future of the keloid treatment market looks promising with opportunities in the hospitals, dermatology clinics, and ambulatory surgical centers (ASCS) markets.

Q5. Who are the key keloid treatment market companies?

Answer: Some of the key keloid treatment companies are as follows.

• Novartis
• Sensus Healthcare
• RXi Pharmaceuticals
• Sonoma Pharmaceuticals
• Perrigo Company
• Bristol-Myers Squibb Company
• Pacific World Corporation
• Valeant Pharmaceuticals International
• Revitol Corporation
• Avita Medical Limited

Q6. Which keloid treatment market segment will be the largest in future?

Answer: Lucintel forecasts that intralesional corticosteroid injections is expected to witness highest growth over the forecast period.

Q7. In keloid treatment market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the keloid treatment market by treatment (occlusive dressing, compression therapy, cryosurgery,excision, radiation therapy, laser therapy, interferon therapy, intralesional corticosteroid injections, and others, ), end use industry (hospitals, dermatology clinics, ambulatory surgical centers (ASCS), and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?